Bellerophon Therapeutics (BLPH) Stock Price, News & Analysis
Company Description
Bellerophon Therapeutics (OTC: BLPH) is classified in the pharmaceutical preparation manufacturing industry within the Manufacturing sector.
BLPH has declined 63.1% over the past year. Shares last traded at $0.0545.
This page collects what Stock Titan holds for BLPH, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bellerophon Therapeutics (BLPH) stock last closed at $0.0545. Over the past 12 months, the stock has lost 63.1%.
Latest News
Bellerophon Therapeutics has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include clinical trial, earnings, offering, fda approval. View all BLPH news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
BLPH Company Profile & Sector Positioning
Bellerophon Therapeutics (BLPH) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.